Incidence of invasive pneumococcal disease in children with commercial insurance or Medicaid coverage in the United States before and after the introduction of 7- and 13-valent pneumococcal conjugate vaccines during 1998–2018

Peer Review reports

Original Submission
11 Jan 2022	Submitted	Original manuscript
19 Mar 2022	Reviewed	Reviewer Report - Naim Ouldali
25 Mar 2022	Reviewed	Reviewer Report
6 Apr 2022	Reviewed	Reviewer Report - Kanica Kaushal
6 Apr 2022	Reviewed	Reviewer Report
26 Jun 2022	Author responded	Author comments - Salini Mohanty
Resubmission - Version 2
26 Jun 2022	Submitted	Manuscript version 2
13 Jul 2022	Author responded	Author comments - Salini Mohanty
Resubmission - Version 3
13 Jul 2022	Submitted	Manuscript version 3
27 Jul 2022	Reviewed	Reviewer Report - Naim Ouldali
Resubmission - Version 4
	Submitted	Manuscript version 4
Publishing
17 Aug 2022	Editorially accepted
5 Sep 2022	Article published	10.1186/s12889-022-14051-6

Back to article page